Researchers have developed a blood test that can reliably detect neuroendocrine prostate cancer and differentiate it from castration-resistant prostate cancer-adenocarcinoma (CRPC-adeno).
Read more https://www.sciencedaily.com/releases/2024/01/240110120221.htm